Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

T. Larsen · SciRah

Researcher profile · Semantic Scholar

T. Larsen

Share profile

T. Larsen — researcher profile on SciRah

h-index: 31
Works: 169
Citations: 3,311

Most-cited papers

Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study
A. Sørensen, S. U. Mikkelsen, T. Knudsen, M. E. Bjørn +16 more
2019Haematologica101 citations Open access
Semantic Scholar
Clinical impact of clonal hematopoiesis in patients with lymphoma undergoing ASCT: a national population-based cohort study
S. Husby, F. Favero, C. Nielsen, B. Sørensen +22 more
2020Leukemia80 citations
Semantic Scholar
Treatment strategies and outcomes in diffuse large B-cell lymphoma among 1011 patients aged 75 years or older: A Danish population-based cohort study.
M. B. Juul, P. H. Jensen, Henriette Engberg, Sonja Wehberg +12 more
2018European Journal of Cancer72 citations
Semantic Scholar
Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84).
P. Lugtenburg, P. de Nully Brown, B. van der Holt, F. d'Amore +30 more
2020Journal of Clinical Oncology71 citations Open access
Semantic Scholar
Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis.
S. Leppä, J. Jørgensen, A. Tierens, L. Meriranta +19 more
2020Blood Advances52 citations Open access
Semantic Scholar
Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses
T. Knudsen, V. Skov, K. Stevenson, L. Werner +28 more
2021Blood Advances51 citations Open access
Semantic Scholar
Safety and efficacy of combination therapy of interferon‐α2 and ruxolitinib in polycythemia vera and myelofibrosis
S. U. Mikkelsen, Lasse Kjær, M. E. Bjørn, T. Knudsen +13 more
2018Cancer Medicine47 citations Open access
Semantic Scholar
Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43)
G. Illerhaus, A. Ferreri, M. Binder, P. Borchmann +46 more
2022Blood39 citations Open access
Semantic Scholar
Glofitamab (Glofit) in Combination with Polatuzumab Vedotin (Pola): Phase Ib/II Preliminary Data Support Manageable Safety and Encouraging Efficacy in Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
M. Hutchings, A. Sureda, M. Terol, Francesc Bosch Albareda +11 more
2021Blood34 citations Open access
Semantic Scholar
Data‐driven analysis of JAK2V617F kinetics during interferon‐alpha2 treatment of patients with polycythemia vera and related neoplasms
R. Pedersen, M. Andersen, T. Knudsen, Z. Sajid +10 more
2020Cancer Medicine32 citations Open access
Semantic Scholar
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine
M. Gigoux, M. Holmström, R. Zappasodi, Joseph J. Park +39 more
2022Science Translational Medicine29 citations
Semantic Scholar
Ocular adnexal lymphoma in Denmark: a nationwide study of 387 cases from 1980 to 2017
Frederik Holm, L. Mikkelsen, P. Kamper, P. Rasmussen +3 more
2020British Journal of Ophthalmology28 citations
Semantic Scholar
Second primary malignancies in patients with lymphoma in Denmark after high-dose chemotherapy and autologous haematopoietic stem-cell transplantation: a population-based, retrospective cohort study.
T. Trab, J. Baech, L. Jakobsen, S. Husby +10 more
2023The Lancet Haematology26 citations
Semantic Scholar
Frequency and etiology of pulmonary hypertension in patients with myeloproliferative neoplasms
M. Brabrand, K. N. Hansen, C. Laursen, T. Larsen +2 more
2019European Journal of Haematology26 citations Open access
Semantic Scholar
Available prognostic models for risk stratification of diffuse large B cell lymphoma patients: a systematic review.
J. Jelicic, T. Larsen, M. Maksimovic, G. Trajković
2019Critical reviews in oncology/hematology22 citations
Semantic Scholar
Glofitamab in Combination with Polatuzumab Vedotin Maintains Durable Responses and a Manageable Safety Profile in Patients with Heavily Pre-Treated Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL) Including High-Grade B-Cell Lymphoma (HGBCL): Extended Follow-up of a Phase Ib/II Study
Martin Hutchings, A. Sureda Balari, F. Bosch, T. Larsen +17 more
2024Blood18 citations Open access
Semantic Scholar
Long-Term Efficacy and Safety of Recombinant Interferon Alpha-2 Vs. Hydroxyurea in Polycythemia Vera: Preliminary Results from the Three-Year Analysis of the Daliah Trial - a Randomized Controlled Phase III Clinical Trial
T. Knudsen, D. Hansen, L. F. Ocias, O. Bjerrum +17 more
2018Blood18 citations Open access
Semantic Scholar
Glofitamab Plus Polatuzumab Vedotin Continues to Demonstrate Frequent and Durable Responses and Has a Manageable Safety Profile in Patients with ≥2L Relapsed/Refractory DLBCL, Including HGBCL, and in Patients with Prior CAR T-Cell Therapy: Updated Results from a Phase Ib/II Study
Martin Hutchings, A. Avigdor, A. Sureda Balari, M. Terol +17 more
2023Blood17 citations Open access
Semantic Scholar
Interferon alpha‐2 treatment reduces circulating neutrophil extracellular trap levels in myeloproliferative neoplasms
L. Massarenti, T. Knudsen, C. Enevold, V. Skov +6 more
2023British Journal of Haematology17 citations Open access
Semantic Scholar
Impact of C-reactive protein and albumin levels on short, medium, and long term mortality in patients with diffuse large B-cell lymphoma
K. O. Gradel, T. Larsen, H. Frederiksen, P. Vinholt +10 more
2022Annals medicus17 citations Open access
Semantic Scholar
Safety and efficacy of durvalumab with R-CHOP or R2-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial
G. Nowakowski, W. Willenbacher, R. Greil, T. Larsen +16 more
2021International journal of hematology16 citations
Semantic Scholar
Risk of death, relapse or progression, and loss of life expectancy at different progression-free survival milestones in primary central nervous system lymphoma
J. Biccler, K. Savage, P. Brown, J. Jørgensen +10 more
2019Leukemia and Lymphoma16 citations
Semantic Scholar
Final Analysis of the Daliah Trial: A Randomized Phase III Trial of Interferon-α Versus Hydroxyurea in Patients with MPN
T. Knudsen, D. Hansen, L. F. Ocias, O. Bjerrum +22 more
2023Blood14 citations Open access
Semantic Scholar
Pretreatment Hemoglobin Adds Prognostic Information To The NCCN-IPI In Patients With Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Containing Chemotherapy
M. Clausen, M. Maurer, S. P. Ulrichsen, T. Larsen +14 more
2019Clinical Epidemiology14 citations Open access
Semantic Scholar
Harnessing the Immune System to Fight Multiple Myeloma
J. Krejcik, M. B. Barnkob, C. Nyvold, T. Larsen +2 more
2021Cancers13 citations Open access
Semantic Scholar
Idelalisib in relapsed/refractory diffuse large B‐cell lymphoma: results from a Nordic Lymphoma Group phase II trial
K. Fjordén, S. Ekberg, N. Kuric, K. Smedby +5 more
2021British Journal of Haematology13 citations Open access
Semantic Scholar
Perspective: Sensitive detection of residual lymphoproliferative disease by clonal gene rearrangements and NGS - How low can you go?
M. Hansen, O. Cédile, T. Larsen, N. Abildgaard +1 more
2021Experimental Hematology12 citations Open access
Semantic Scholar
Revisiting beta‐2 microglobulin as a prognostic marker in diffuse large B‐cell lymphoma
J. Jelicic, K. Juul-Jensen, Z. Bukumirić, Mikkel Runason Simonsen +8 more
2024Cancer Medicine11 citations Open access
Semantic Scholar
THE CLINICAL APPLICABILITY OF CURRENT PROGNOSTIC MODELS IN FOLLICULAR LYMPHOMA: A SYSTEMATIC REVIEW.
J. Jelicic, T. Larsen, Z. Bukumirić, B. Andjelic
2021Critical reviews in oncology/hematology11 citations Open access
Semantic Scholar
Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL
S. Husby, Cecilie Bæch-Laursen, C. Eskelund, F. Favero +10 more
2022Leukemia9 citations
Semantic Scholar
Statistical Challenges in Development of Prognostic Models in Diffuse Large B-Cell Lymphoma: Comparison Between Existing Models – A Systematic Review
J. Jelicic, T. Larsen, H. Frederiksen, B. Andjelic +2 more
2020Clinical Epidemiology9 citations Open access
Semantic Scholar
Safety and efficacy of PD-L1 inhibitor durvalumab with R-CHOP or R2-CHOP in subjects with previously untreated, high-risk DLBCL.
G. Nowakowski, W. Willenbacher, R. Greil, T. Larsen +15 more
2019Journal of Clinical Oncology9 citations Open access
Semantic Scholar
IGHV-associated methylation signatures more accurately predict clinical outcomes of chronic lymphocytic leukemia patients than IGHV mutation load
Dianna Hussmann, A. Starnawska, L. Kristensen, I. Daugaard +12 more
2021Haematologica8 citations Open access
Semantic Scholar
Significantly Upregulated Thrombo-Inflammatory Genes Are Normoregulated or Significantly Downregulated during Treatment with Interferon-Alpha2 in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms
V. Skov, C. Riley, M. Thomassen, Lasse Kjær +3 more
2019Blood8 citations Open access
Semantic Scholar
Real‐world outcomes following third or subsequent lines of therapy: A Danish population‐based study on 189 patients with relapsed/refractory large B‐cell lymphomas
A. Al-Mashhadi, L. Jakobsen, Peter Brown, A. Gang +17 more
2023British Journal of Haematology7 citations Open access
Semantic Scholar
Reproduction patterns among non‐Hodgkin lymphoma survivors by subtype in Sweden, Denmark and Norway: A population‐based matched cohort study
J. Entrop, C. Weibull, K. Smedby, L. Jakobsen +9 more
2023British Journal of Haematology7 citations Open access
Semantic Scholar
GLOFITAMAB PLUS POLATUZUMAB VEDOTIN DEMONSTRATES DURABLE RESPONSES AND A MANAGEABLE SAFETY PROFILE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA
M. Hutchings, A. Avigdor, A. Sureda, M. Terol +18 more
2023Hematological Oncology7 citations Open access
Semantic Scholar
PROGNOSTIC MODELS IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA PATIENTS: A systematic review.
J. Jelicic, T. Larsen, Z. Bukumirić, K. Juul-Jensen +1 more
2021Critical reviews in oncology/hematology7 citations
Semantic Scholar
Should we use nomograms for risk predictions in diffuse large B cell lymphoma patients? A systematic review.
J. Jelicic, T. Larsen, B. Andjelic, K. Juul-Jensen +1 more
2024Critical reviews in oncology/hematology6 citations Open access
Semantic Scholar
Effectiveness of R‐CHOP versus R‐CHOEP for treatment of young patients with high‐risk diffuse large B‐cell lymphoma: A Danish observational population‐based study
Rasmus Rask Kragh Jørgensen, L. Jakobsen, S. Eloranta, K. Smedby +9 more
2024European Journal of Haematology6 citations Open access
Semantic Scholar
A retrospective head‐to‐head comparison of the Lugano classification and PERCIST for FDG‐PET/CT response assessment in diffuse large B‐cell lymphoma
N. Nielsen, O. Gerke, A. L. Nielsen, K. Juul-Jensen +3 more
2023Clinical Physiology and Functional Imaging5 citations Open access
Semantic Scholar
CONSOLIDATIVE HCT‐ASCT IS SUPERIOR TO NON‐MYELOABLATIVE CHEMO‐IMMUNOTHERAPY IN NEWLY‐DIAGNOSED PCNSL ‐ UPDATED RESULTS OF THE RANDOMIZED PHASE III MATRIX/IELSG43 TRIAL
G. Illerhaus, A. Ferreri, M. Binder, P. Borchmann +46 more
2023Hematological Oncology5 citations Open access
Semantic Scholar
Cardiovascular diseases after high‐dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population‐based study
J. Baech, S. Husby, T. Trab, K. Kragholm +12 more
2023British Journal of Haematology5 citations Open access
Semantic Scholar
Clinical Characteristics and Management of Patients With Concomitant Liver Cirrhosis and Lymphoma: A Systematic Review.
J. Jelicic, T. Larsen, A. Fialla, Z. Bukumirić +1 more
2022Clinical Lymphoma, Myeloma & Leukemia5 citations
Semantic Scholar
Maintenance of CD19 Expression after Tafasitamab Treatment in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) from Clinical Trial and Real-World Settings
J. Duell, Diana Alvarez Arias, H. Rauert-Wunderlich, F. Eisele +4 more
2024Blood4 citations
Semantic Scholar
Work Disability and Return to Work After Lymphoma: A Danish Nationwide Cohort Study
E. Maksten, L. Jakobsen, K. Kragholm, J. Baech +13 more
2023Clinical Epidemiology4 citations Open access
Semantic Scholar
A Phase 3 Study of Tafasitamab Plus Lenalidomide in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (firmMIND)
T. Larsen, O. Manzke, Daniel Leibovitz, M. Arbushites
2022Blood4 citations Open access
Semantic Scholar
Interferon-alfa2 Treatment of Patients with Polycythemia Vera and Related Neoplasms Influences Deregulated Inflammation and Immune Genes in Polycythemia Vera and Allied Neoplasms
V. Skov, C. Riley, M. Thomassen, Lasse Kjær +4 more
2018Blood4 citations Open access
Semantic Scholar
CD19 expression in diffuse large B-cell lymphoma (DLBCL) patient biopsies after treatment with tafasitamab.
Alla Volgina, B. Rumberger, Hrefna S. Jóhannsdóttir, T. Larsen +1 more
2024Journal of Clinical Oncology3 citations
Semantic Scholar
Extracellular Matrix-Related Genes Are Deregulated in Peripheral Blood from Patients with Myelofibrosis and Related Neoplasms
V. Skov, M. Thomassen, Lasse Kjær, C. Riley +4 more
2018Blood3 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

V. Skov×11
Invite
V. Skov — researcher profile on SciRah
H. Hasselbalch×11
Invite
H. Hasselbalch — researcher profile on SciRah
Lasse Kjær×10
Invite
Lasse Kjær — researcher profile on SciRah
T. El-Galaly×10
Invite
T. El-Galaly — researcher profile on SciRah

×10

Invite

J. Jørgensen — researcher profile on SciRah

Invite

J. Jelicic — researcher profile on SciRah

Invite

T. Knudsen — researcher profile on SciRah

Invite

T. Kruse — researcher profile on SciRah

M. Thomassen×8

Invite

M. Thomassen — researcher profile on SciRah

Invite

O. Bjerrum — researcher profile on SciRah

Invite

L. Jakobsen — researcher profile on SciRah

Invite

D. Hansen — researcher profile on SciRah